EDNRB

EDNRB

EDNRB Molekülinformation

Molecule Name
Endothelin receptor type B
Molekülalias
EDNRB,endothelin receptor type B,ABCDS, ET-B, ET-BR, ETB, ETB1, ETBR, ETRB, HSCR, HSCR2, WS4A
Drug Development Progress
Anzahl der klinischen Arzneimittel5
Anzahl der inverkehr gebrachten Arzneimittel5
Höchste Forschungs- und EntwicklungsphaseApproved
Target-Alias
Hirschsprung Disease 2,Endothelin receptor non-selective type,ET-B,Endothelin receptor type B,EDNRB,ET-BR,ETRB,Endothelin Receptor Subtype B1,ABCDS,HSCR2,ETB1,ETBR,WS4A,HSCR,ETB,Receptor, Endothelin B
Molekülhintergrund
Endothelin Receptor B (EDNRB) is a type of G protein-coupled Receptor with the N-terminus located outside the cell. It's widespread in the human body. EDNRB binds to ET and transmits information into the cell through the intracellular Ca2+ phospholipid-dependent protein kinase second messenger system, which promotes the rapid release of calcium in the endoplasmic reticulum and sarcoplasmic reticulum, resulting in the rapid increase of intracellular calcium concentration. Endothelin exerts its biological effects through its receptor (ETR). Endothelin and ETR constitute the endothelin axis. Endothelin axis has pro-tumor effects in various tumors including malignant melanoma (MM), including promoting tumor growth, anti-apoptosis, promoting angiogenesis and promoting tumor metastasis.

EDNRB Produktliste

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
VRP-1620VRP-1620Phase 3 ClinicalUniversity Of Illinois
Breast Neoplasms
Details
VodudeutentanENB-003; ENB-006Phase 2 ClinicalEnb Therapeutics Inc
Melanoma; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Solid tumours
Details
BQ-788BQ-788Phase 1 ClinicalMerck Serono
Cardiovascular Diseases; Hypertension; Melanoma
Details
GLX-002GLX-002; GLX002Phase 1 ClinicalYabao Pharmaceutical Co Ltd Beijing
Pulmonary Arterial Hypertension
Details
Bosentan Orally Disintegrating Tablets(Beijing Sunho Pharma)Phase 1 ClinicalBeijing Sunho Pharmaceutical Co Ltd
Pulmonary Arterial Hypertension
Details

Inverkehr gebrachte Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaFrühestes MarkennameFrühestes GenehmigungslandFrüheste IndikationFrüheste GenehmigungsgesellschaftFrüheste GenehmigungsdatumIndikationenKlinische Studie
SovateltideIRL-1620; PMZ-1620; SPI-1620ApprovedUniversity Of Illinois At ChicagoTyvalziIndiaStrokePharmazz Inc2023-05-31
Alzheimer Disease; Asphyxia Neonatorum; Biliary Tract Neoplasms; Brain Diseases; Brain Ischemia; Carcinoma; Carcinoma, Non-Small-Cell Lung; Cerebral Infarction; Dementia; Ischemic Stroke; Spinal Cord Injuries; Stroke
Details
Macitentan/TadalafilApprovedActelion Pharmaceuticals LtdOPSYNVI, YuvanciUnited StatesPulmonary Arterial HypertensionActelion Pharmaceuticals Us Inc2024-03-22
Phenylketonurias; Pulmonary Arterial Hypertension
Details
Bosentan HydrateACT-050088; HGP-1206; Ro-47-0203; Ro-47-0203/029; Ro-47-0203/039ApprovedF. Hoffmann-La Roche LtdStayveer, 全可利, TracleerUnited StatesPulmonary Arterial HypertensionActelion Pharmaceuticals Ltd2001-11-20
Anemia, Sickle Cell; Chronic thromboembolic pulmonary hypertension; Coronary Vasospasm; Diabetes Mellitus; Diabetes Mellitus, Type 2; Fibrosis; Giant Cell Arteritis; Glaucoma; Heart Defects, Congenital; Heart Septal Defects, Atrial; Hepatopulmonary Syndrome; Hypertension; Hypertension, Pulmonary; Idiopathic Pulmonary Fibrosis; Liver Cirrhosis; Lung Diseases, Interstitial; Persistent Fetal Circulation Syndrome; Pulmonary Arterial Hypertension; Pulmonary Fibrosis; Sarcoidosis; Scleroderma, Systemic; Sleep Apnea Syndromes; Takayasu Arteritis; Ulcer; Vasculitis
Details
MacitentanACT-064992; Actelion-1; JNJ-67896062ApprovedActelion Pharmaceuticals LtdZependo, Opsumit, 傲朴舒United StatesPulmonary Arterial HypertensionActelion Pharmaceuticals Us Inc2013-10-18
Anemia, Sickle Cell; Angina Pectoris; Chronic Disease; Chronic thromboembolic pulmonary hypertension; Eisenmenger Complex; Glioblastoma; Heart Defects, Congenital; Heart Failure; Heart Failure, Diastolic; Hypertension, Pulmonary; Idiopathic Pulmonary Fibrosis; Pulmonary Arterial Hypertension; Pulmonary Embolism; Scleroderma, Systemic; Scleroderma-associated interstitial lung diseases; Thromboembolism; Ulcer
Details
AprocitentanACT-132577; AC-080; JNJ-2820ApprovedActelion Pharmaceuticals Ltd, Idorsia Pharmaceuticals LtdTRYVIO, JERAYGOUnited StatesHypertensionIdorsia Pharmaceuticals Ltd2024-03-19
Essential Hypertension; Hepatic Insufficiency; Hypertension; Renal Insufficiency, Chronic
Details